Clinical applications of IL6 inhibitors
- 31 December 1992
- journal article
- review article
- Published by Elsevier BV in Research in Immunology
- Vol. 143 (7), 774-776
- https://doi.org/10.1016/0923-2494(92)80022-d
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Interleukin-6 dependence of advanced malignant plasma cell dyscrasiasCancer, 1992
- 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens.JCI Insight, 1992
- Human recombinant dimeric IL-6 binds to its receptor as detected by anti-IL-6 monoclonal antibodiesMolecular Immunology, 1991
- Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.The Journal of Experimental Medicine, 1991
- Letter to the editor: The bone-resorbing activity of interleukin-6Journal of Bone and Mineral Research, 1991
- Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemiaBlood, 1991
- Diphtheria toxin receptor-binding domain substitution with interleukin 6: genetic construction and interleukin 6 receptor-specific action of a diphtheria toxin-related interleukin 6 fusion proteinProtein Engineering, Design and Selection, 1991
- Biological and clinical aspects of interleukin 6Immunology Today, 1990
- Glucocorticoids inhibit the production of IL 6 from monocytes, endothelial cells and fibroblastsEuropean Journal of Immunology, 1990
- Production and regulation of interleukin 6 in human B lymphoid cellsEuropean Journal of Immunology, 1990